ConductScience.org, home

Paper34400331

Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies.

Baik AD and 21 others. Mol Ther, 2021. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies. Papers, record 34400331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34400331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies.
PubMed
Journal
Mol Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2022-12-02
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baik ADAndrew D
2Calafati PPhilip
3Zhang XXiaoli
4Aaron NANina A
5Mehra AAntonia
6Moller-Tank SSven
7Miloscio LLawrence
8Praggastis MMaria
9Giovannone NNicholas
10Pan CCheryl
11Tang YYajun
12Bridges SSusannah
13Mujica AAlejo
14Barbounis PPeter
15Yanolatos JJean
16Gale NNicholas
17Li NNing
18Kyratsous CAChristos A
19Schoenherr CJChristopher J
20Murphy AJAndrew J

Source PubMed

See all 22 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glycogen Storage Disease Type IIMajor topic
Lysosomal Storage DiseasesMajor topic
Animals
Enzyme Replacement Therapy
Hydrolases
Lysosomes
Mice
Tissue Distribution
alpha-Glucosidases

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125613900Proteomics. Tissue-based map of the human proteome.Science2015https://conductscience.org/library/papers/25613900PubMed
29668092Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II.J Biol Chem1998https://conductscience.org/library/papers/9668092PubMed
327896120Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease.Mol Genet Metab Rep2014https://conductscience.org/library/papers/27896120PubMed
428874182Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.Acta Neuropathol Commun2017https://conductscience.org/library/papers/28874182PubMed
524706856Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24706856PubMed
68126096Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases.J Cell Sci1993https://conductscience.org/library/papers/8126096PubMed
721397538Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.Mol Genet Metab2011https://conductscience.org/library/papers/21397538PubMed
823060045Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease.Genet Med2013https://conductscience.org/library/papers/23060045PubMed
922538254The emerging phenotype of long-term survivors with infantile Pompe disease.Genet Med2012https://conductscience.org/library/papers/22538254PubMed
1024954473Liver-specific transcriptional modules identified by genome-wide in silico analysis enable efficient gene therapy in mice and non-human primates.Mol Ther2014https://conductscience.org/library/papers/24954473PubMed
1122970722Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.Annu Rev Genomics Hum Genet2012https://conductscience.org/library/papers/22970722PubMed
1222266136Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction.Mol Genet Metab2012https://conductscience.org/library/papers/22266136PubMed
1318500944Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice.Hum Gene Ther2008https://conductscience.org/library/papers/18500944PubMed
1425537451Therapies for the bone in mucopolysaccharidoses.Mol Genet Metab2015https://conductscience.org/library/papers/25537451PubMed
1530291246Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.Nat Commun2018https://conductscience.org/library/papers/30291246PubMed
1623188827Glycosylation-independent lysosomal targeting of acid α-glucosidase enhances muscle glycogen clearance in pompe mice.J Biol Chem2013https://conductscience.org/library/papers/23188827PubMed
1717680664Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.Biotechnol Bioeng2008https://conductscience.org/library/papers/17680664PubMed
1811278916The integrin alpha 7 cytoplasmic domain regulates cell migration, lamellipodia formation, and p130CAS/Crk coupling.J Biol Chem2001https://conductscience.org/library/papers/11278916PubMed
1915520017Lysosomal acid alpha-glucosidase consists of four different peptides processed from a single chain precursor.J Biol Chem2005https://conductscience.org/library/papers/15520017PubMed
2031392203Challenges in treating Pompe disease: an industry perspective.Ann Transl Med2019https://conductscience.org/library/papers/31392203PubMed

See all 46 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
41491260Assessment of Immune Responses Against AAV Encoded Transgene Products.AAPS J2026https://conductscience.org/library/papers/41491260PubMed
40268518Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease.Clin Transl Med2025https://conductscience.org/library/papers/40268518PubMed
39134822Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy.Mol Diagn Ther2024https://conductscience.org/library/papers/39134822PubMed
38543765Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials.Viruses2024https://conductscience.org/library/papers/38543765PubMed
38033727Bringing enzymes to the proximity party.RSC Chem Biol2023https://conductscience.org/library/papers/38033727PubMed
37759559Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes.Biology (Basel)2023https://conductscience.org/library/papers/37759559PubMed
36969713Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview.Curr Treat Options Neurol2022https://conductscience.org/library/papers/36969713PubMed
36657645Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.Adv Drug Deliv Rev2023https://conductscience.org/library/papers/36657645PubMed
35787971A rapid and non-invasive proteomic analysis using DBS and buccal swab for multiplexed second-tier screening of Pompe disease and Mucopolysaccharidosis type I.Mol Genet Metab2022https://conductscience.org/library/papers/35787971PubMed
35203513Gene Therapy Developments for Pompe Disease.Biomedicines2022https://conductscience.org/library/papers/35203513PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34400331

GET https://conductscience.org/api/papers/v1/34400331/authors?page=2